Halitosis
Conditions
Interventions
This is a planned, two-arm, triple-blind clinical trial, programmed with 36 individuals diagnosed with halitosis, randomly allocated into two groups of 18 participants each. The randomization sequence
s availability to return, and the effective usage time was recorded in the individual clinical record
Sponsors
Faculdade Meridional
Faculdade Meridional
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Volunteers with halitosis confirmed by organoleptic evaluation and positive self-perception of halitosis, aged 18 years or older.
Exclusion criteria
Exclusion criteria: Volunteers with uncontrolled diabetes, liver disorders, recurrent oropharyngeal infections, flu-like symptoms, use of dental prostheses, recent oral surgical procedures, and penicillin and metronidazole medications were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An improvement in halitosis is expected, assessed by organoleptic testing with a reduction of at least 2 points on the halitosis scale. Data will be collected one week before the intervention and two weeks after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactLilian Rigo
Faculdade Meridional
Outcome results
None listed